1. Home
  2. FLXS vs MGNX Comparison

FLXS vs MGNX Comparison

Compare FLXS & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

HOLD

Current Price

$65.26

Market Cap

257.1M

ML Signal

HOLD

Logo MacroGenics Inc.

MGNX

MacroGenics Inc.

HOLD

Current Price

$4.12

Market Cap

220.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLXS
MGNX
Founded
2001
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.1M
220.6M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
FLXS
MGNX
Price
$65.26
$4.12
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$54.00
$5.00
AVG Volume (30 Days)
38.6K
609.3K
Earning Date
04-20-2026
05-08-2026
Dividend Yield
1.41%
N/A
EPS Growth
N/A
N/A
EPS
3.63
N/A
Revenue
$441,073,000.00
$149,500,000.00
Revenue This Year
$4.51
N/A
Revenue Next Year
$4.89
$3.19
P/E Ratio
$17.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.65
$1.19
52 Week High
$65.03
$4.64

Technical Indicators

Market Signals
Indicator
FLXS
MGNX
Relative Strength Index (RSI) 70.91 55.21
Support Level $52.27 $1.49
Resistance Level N/A $4.55
Average True Range (ATR) 2.49 0.25
MACD 0.50 -0.04
Stochastic Oscillator 95.81 47.29

Price Performance

Historical Comparison
FLXS
MGNX

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About MGNX MacroGenics Inc.

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which it refers to as DART and TRIDENT molecules). It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its segment is developing and commercializing monoclonal antibody-based therapeutics.

Share on Social Networks: